search
Back to results

Colloid Infusion for Optimal Outcomes In Non-cardiac Surgery (COIN Trial) (COIN)

Primary Purpose

Postoperative Complications

Status
Recruiting
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Hydroxyethyl Starch 130/0.4 and Electrolyte injection of 5ml/kg
Multiple Electrolytes injection of 5 ml/kg
Sponsored by
Xijing Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Postoperative Complications

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: 18 years or older ASA I-III Undergoing elective non-cardiac surgery under general aneathesia Exclusion Criteria: Allergic to colloids Severe heart diseases ( Ejection Fraction lower than 35%) Presence of renal failure pre-operatively (defined as eGFR < 30 mL/min/1.73 m2 and/or patient receiving renal replacement therapy) Morbid obesity (BMI > 37.5kg/m2 or > 32.5kg/m2 with metabolic diseases) Presence of a coagulopathy at screening (defined as platelet count < 100 × 109/L and/or a prothrombin time < 70% and/or an activated partial thromboplastin time (aPTT) >35 s and/or fibrinogen <1 g/ L) Presence of liver injury (defined as Child-Pugh C) Pre-operative electrolyte disturbances with Na >160 mmol/L or <120 mmol/L Patients with preoperative intracranial hypertension requiring dehydration treatment

Sites / Locations

  • Xijing HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

colloid group

crystalloid group

Arm Description

The participants in colloid group will received intravenous Hydroxyethyl Starch 130/0.4 and Electrolyte injection of 5ml/kg before the Induction of general anesthesia.

The participants in crystalloid group will received intravenous multiple electrolyte injection of 5ml/kg before the Induction of general anesthesia.

Outcomes

Primary Outcome Measures

The incidence of post-operative complications
Modified Clavien-Dindo Classification ≥ grade I

Secondary Outcome Measures

Post-induction hypotension (PIH)
MAP < 65mmHg or 20% lower than the baseline from the time of anesthsia induction to incison
The doses of vasopressors and inotropes
including epinephrine, norepinephrine, dopamine.
Lengths of stay in hospital (LOS) post-operatively
The time from the end of operation to discharge from hospital
the incidence of optimal recovery
Defined as discharge within 5 days of surgery with no major complications (Clavien-Dindo ≥ III), no infections of incisions, no re-admissions to hospital, and no deaths post-operatively

Full Information

First Posted
December 26, 2022
Last Updated
August 17, 2023
Sponsor
Xijing Hospital
Collaborators
Ningbo No.2 Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT05728645
Brief Title
Colloid Infusion for Optimal Outcomes In Non-cardiac Surgery (COIN Trial)
Acronym
COIN
Official Title
Effect of Colloid or Crystalloid Infusion Before Induction of General Anesthesia on Postoperative Complications Within 30 Days
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
July 12, 2023 (Actual)
Primary Completion Date
December 31, 2023 (Anticipated)
Study Completion Date
January 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Xijing Hospital
Collaborators
Ningbo No.2 Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Hypotension is associated with postoperative complications. Preoperative fluid infusion can effectively prevent post-induction hypotension of general anesthesia. Previous studies only focused on the hemodynamics after preoperative fluid infusion. Pre-operative fluid infusion can reduce the incidence of post-operative complications by preventing post-induction hypotension. The patients who is 18 years or older and undergo elective non-cardiac surgery with general anesthsia will be enrolled. The intervention is intravenous infusion of colloids or crytalloids before induction of general anesthesia. The primary outcome is the incidence of post-operative complications within 30 days.
Detailed Description
Post-induction hypotension occurs in 30-40% of patients undergoing surgery under general anesthesia. Perioperative hypotension is a significant independent risk factor for post-operative myocardial injury, acute kidney injury, stroke, and significantly increases 30-day mortality rate after surgery. Perioperative hypotension has been attributed to absolute or relative hypovolaemia secondary to pre-operative fasting and to the vasodilatory and negative inotropic effects of certain induction agents. Low baseline blood volume is a risk factor for post-induction hypotension. The general consensus remains that patients entering the operating room require fluids to make up for reduced pre-operative intake. Intravenous administration of 500 mL of crystalloid solution before induction of anaesthesia did not decrease the overall incidence of cardiovascular collapse during tracheal intubation of critically ill adults compared with no fluid bolus. Among patients in the intensive care unit requiring fluid challenges, intravenous crystalloid boluses of 250 ml before intubation did not reduce 90-day mortality. Preloading colloids reduced the occurrence of post-induction hypotension and vasopressor use, improved CI, and reduced SVV during the early intraoperative period. It is unknown whether pre-operative colloids infusion can reduce the incidence of post-operative complications by preventing post-induction hypotension. We will enroll patients with 18 years or older and undergoing elective surgery under general anesthsia. The participants in colloid group will receive intravenous colloids 5ml/kg before induction of anesthesia; who in crystalloid group will receive intravenous Ringer's solution 5ml/kg before induction of anesthesia. The primary outcome in this study is the incidence of post-operative complications (Clavien-Dindo) within 30 days. The secondary outcomes include the incidence of post-induction hypotension, the doses of vasopressors and inotropes intra-operatively, lengths of stay in hospital (LOS) post-operatively, optimal recovery post-operatively within 5 days.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Postoperative Complications

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
1848 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
colloid group
Arm Type
Experimental
Arm Description
The participants in colloid group will received intravenous Hydroxyethyl Starch 130/0.4 and Electrolyte injection of 5ml/kg before the Induction of general anesthesia.
Arm Title
crystalloid group
Arm Type
Active Comparator
Arm Description
The participants in crystalloid group will received intravenous multiple electrolyte injection of 5ml/kg before the Induction of general anesthesia.
Intervention Type
Drug
Intervention Name(s)
Hydroxyethyl Starch 130/0.4 and Electrolyte injection of 5ml/kg
Other Intervention Name(s)
colloid infusion
Intervention Description
Intravenous Hydroxyethyl Starch 130/0.4 and Electrolyte injection of 5ml/kg before induction of general anesthesia
Intervention Type
Drug
Intervention Name(s)
Multiple Electrolytes injection of 5 ml/kg
Other Intervention Name(s)
Crystalloid infusion
Intervention Description
Intravenous Multiple Electrolytes injection of 5ml/kg before induction of general anesthesia
Primary Outcome Measure Information:
Title
The incidence of post-operative complications
Description
Modified Clavien-Dindo Classification ≥ grade I
Time Frame
within 30 days after operation
Secondary Outcome Measure Information:
Title
Post-induction hypotension (PIH)
Description
MAP < 65mmHg or 20% lower than the baseline from the time of anesthsia induction to incison
Time Frame
during procedure ( the time from induction of anesthesia to incision)
Title
The doses of vasopressors and inotropes
Description
including epinephrine, norepinephrine, dopamine.
Time Frame
intra-operatively,the time from induction of anesthesia to discharge from operating room
Title
Lengths of stay in hospital (LOS) post-operatively
Description
The time from the end of operation to discharge from hospital
Time Frame
postoperatively within 30 days
Title
the incidence of optimal recovery
Description
Defined as discharge within 5 days of surgery with no major complications (Clavien-Dindo ≥ III), no infections of incisions, no re-admissions to hospital, and no deaths post-operatively
Time Frame
post-operatively within 5 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 18 years or older ASA I-III Undergoing elective non-cardiac surgery under general aneathesia Exclusion Criteria: Allergic to colloids Severe heart diseases ( Ejection Fraction lower than 35%) Presence of renal failure pre-operatively (defined as eGFR < 30 mL/min/1.73 m2 and/or patient receiving renal replacement therapy) Morbid obesity (BMI > 37.5kg/m2 or > 32.5kg/m2 with metabolic diseases) Presence of a coagulopathy at screening (defined as platelet count < 100 × 109/L and/or a prothrombin time < 70% and/or an activated partial thromboplastin time (aPTT) >35 s and/or fibrinogen <1 g/ L) Presence of liver injury (defined as Child-Pugh C) Pre-operative electrolyte disturbances with Na >160 mmol/L or <120 mmol/L Patients with preoperative intracranial hypertension requiring dehydration treatment
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Chong Lei, M.D., Ph.D.
Phone
+862984775343
Email
Crystalleichong@126.com
Facility Information:
Facility Name
Xijing Hospital
City
Xi'an
State/Province
Shaanxi
ZIP/Postal Code
710032
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Chong Lei, M.D., Ph.D.,
Phone
86-18629011362
Email
leichongbb@gmail.com
First Name & Middle Initial & Last Name & Degree
Chong Lei, M.D., Ph.D.,

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Colloid Infusion for Optimal Outcomes In Non-cardiac Surgery (COIN Trial)

We'll reach out to this number within 24 hrs